Elevated Levels of the Anti-Inflammatory Interleukin-1 Receptor Antagonist Precede the Onset of Type 2 Diabetes
Year: 2008
Type: article
Study design: Observational Study
Abstract: OBJECTIVE: Interleukin-1 receptor antagonist (IL-1Ra), a natural inhibitor of interleukin-1 beta, has been shown to improve beta-cell function and glycemic control in patients with type 2 diabetes. The aim of this study was to investigate whether baseline systemic levels of IL-1Ra are associated with incident type 2 diabetes during more than 10 years of follow-up. RESEARCH DESIGN AND METHODS: We measured serum IL-1Ra concentrations in a nested case-control study (181 case and 376 age-, sex-, and BMI-matched normoglycemic control subjects) within the Whitehall II cohort (U.K.). RESULTS: IL-1Ra concentrations were higher in case subjects (P = 0.0006) and associated with incident type 2 diabetes (odds ratio for a 1-SD increase of IL-1Ra 1.48 [95% CI 1.21-1.80]). This association remained significant after adjustment for multiple potential confounders but was attenuated by adjusting for 2-h glucose. CONCLUSIONS: Our findings indicate that individuals who will develop type 2 diabetes are characterized by a complex immune activation that also includes upregulation of the anti-inflammatory cytokine IL-1Ra.
Source: Diabetes Care
DOI: 10.2337/dc08-1161
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Funders: John D. and Catherine T. MacArthur Foundation, National Institute for Health and Care Research, British Heart Foundation, Health and Safety Executive, Bundesministerium für Gesundheit, National Institutes of Health, Agency for Healthcare Research and Quality, Medical Research Council, Economic and Social Research Council, National Institute on Aging, National Heart, Lung, and Blood Institute
Awards: G2307454678, G4722625316, G6354209809, CHANGES IN HEALTH: SOCIO-ECONOMIC STATUS AND PATHWAYS, Psycho-social and biological factors in the occurrence of cardiovascular disease: The Whitehall II study, Socio-economic status and heterogeneity in aging, Socioeconomic gradient in CHD in early old age
OpenAlex ID: W2074685860
